129 related articles for article (PubMed ID: 34838717)
1. Oral human papillomavirus (HPV) and associated factors among healthy populations: The design of the PROGRESS (PRevalence of Oral hpv infection, a Global aSSessment) study.
Morais E; Kothari S; Roberts C; Yen G; Chen YT; Lynam M; Pedrós M; Mirghani H; Alemany L; Pavon MA; Waterboer T; Mehanna H; Giuliano AR
Contemp Clin Trials; 2022 Apr; 115():106630. PubMed ID: 34838717
[TBL] [Abstract][Full Text] [Related]
2. Oral Human Papillomavirus Prevalence and Genotyping Among a Healthy Adult Population in the US.
Giuliano AR; Felsher M; Waterboer T; Mirghani H; Mehanna H; Roberts C; Chen YT; Lynam M; Pedrós M; Sanchez E; Sirak B; Surati S; Alemany L; Morais E; Pavón MA
JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):783-795. PubMed ID: 37535349
[TBL] [Abstract][Full Text] [Related]
3. Oral HPV prevalence assessment by Linear Array vs. SPF
Bettampadi D; Sirak BA; Fulp WJ; Abrahamsen M; Villa LL; Lazcano-Ponce E; Salmeron J; Isaacs-Soriano KA; Baggio ML; Trenado MQ; Giuliano AR
Papillomavirus Res; 2020 Jun; 9():100199. PubMed ID: 32464335
[TBL] [Abstract][Full Text] [Related]
4. Six-month incidence and persistence of oral HPV infection in HIV-negative and HIV-infected men who have sex with men.
Mooij SH; Boot HJ; Speksnijder AG; Meijer CJ; King AJ; Verhagen DW; de Vries HJ; Quint WG; Molijn A; de Koning MN; van der Sande MA; van der Loeff MF
PLoS One; 2014; 9(6):e98955. PubMed ID: 24896848
[TBL] [Abstract][Full Text] [Related]
5. Factors Associated With Persistence and Clearance of High-Risk Oral Human Papillomavirus (HPV) Among Participants in the HPV Infection in Men (HIM) Study.
Bettampadi D; Sirak BA; Abrahamsen ME; Reich RR; Villa LL; Ponce EL; Giuliano AR
Clin Infect Dis; 2021 Nov; 73(9):e3227-e3234. PubMed ID: 33173937
[TBL] [Abstract][Full Text] [Related]
6. Twelve-month incidence and clearance of oral HPV infection in HIV-negative and HIV-infected men who have sex with men: the H2M cohort study.
van Aar F; Mooij SH; van der Sande MA; Meijer CJ; King AJ; Verhagen DW; Heijman T; Coutinho RA; Schim van der Loeff MF
BMC Infect Dis; 2014 Dec; 14():668. PubMed ID: 25551194
[TBL] [Abstract][Full Text] [Related]
7. Oral human papillomavirus infection in HIV-negative and HIV-infected MSM.
Mooij SH; Boot HJ; Speksnijder AG; Stolte IG; Meijer CJ; Snijders PJ; Verhagen DW; King AJ; de Vries HJ; Quint WG; van der Sande MA; Schim van der Loeff MF
AIDS; 2013 Aug; 27(13):2117-28. PubMed ID: 24384590
[TBL] [Abstract][Full Text] [Related]
8. Oral human papillomavirus prevalence, persistence, and risk-factors in HIV-positive and HIV-negative adults.
Riddell J; Brouwer AF; Walline HM; Campredon LP; Meza R; Eisenberg MC; Andrus EC; Delinger RL; Yost ML; McCloskey JK; Thomas TB; Huang S; Ferris RL; Shin DM; Fakhry C; Ow T; Li D; Berlot A; Carey TE; Schlecht NF
Tumour Virus Res; 2022 Jun; 13():200237. PubMed ID: 35460939
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of oral HPV infection in the United States, 2009-2010.
Gillison ML; Broutian T; Pickard RK; Tong ZY; Xiao W; Kahle L; Graubard BI; Chaturvedi AK
JAMA; 2012 Feb; 307(7):693-703. PubMed ID: 22282321
[TBL] [Abstract][Full Text] [Related]
10. Human Papilloma Virus (HPV) Oral Prevalence in Scotland (HOPSCOTCH): A Feasibility Study in Dental Settings.
Conway DI; Robertson C; Gray H; Young L; McDaid LM; Winter AJ; Campbell C; Pan J; Kavanagh K; Kean S; Bhatia R; Cubie H; Clarkson JE; Bagg J; Pollock KG; Cuschieri K
PLoS One; 2016; 11(11):e0165847. PubMed ID: 27861508
[TBL] [Abstract][Full Text] [Related]
11. Natural history of human papillomavirus infections involving anal, penile, and oral sites among HIV-positive men.
Videla S; Darwich L; Cañadas MP; Coll J; Piñol M; García-Cuyás F; Molina-Lopez RA; Cobarsi P; Clotet B; Sirera G;
Sex Transm Dis; 2013 Jan; 40(1):3-10. PubMed ID: 23250297
[TBL] [Abstract][Full Text] [Related]
12. Oral human papillomavirus prevalence and type distribution by country (Brazil, Mexico and the United States) and age among HPV infection in men study participants.
Bettampadi D; Villa LL; Ponce EL; Salmeron J; Sirak BA; Abrahamsen M; Rathwell JA; Reich RR; Giuliano AR
Int J Cancer; 2020 Jun; 146(11):3026-3033. PubMed ID: 31583681
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and Determinants of Oral Human Papillomavirus Infection in 500 Young Adults from Italy.
Lupato V; Holzinger D; Höfler D; Menegaldo A; Giorgi Rossi P; Del Mistro A; Da Mosto MC; Pawlita M; Boscolo-Rizzo P
PLoS One; 2017; 12(1):e0170091. PubMed ID: 28103272
[TBL] [Abstract][Full Text] [Related]
14. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study.
Kreimer AR; Pierce Campbell CM; Lin HY; Fulp W; Papenfuss MR; Abrahamsen M; Hildesheim A; Villa LL; Salmerón JJ; Lazcano-Ponce E; Giuliano AR
Lancet; 2013 Sep; 382(9895):877-87. PubMed ID: 23827089
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults.
Beachler DC; Sugar EA; Margolick JB; Weber KM; Strickler HD; Wiley DJ; Cranston RD; Burk RD; Minkoff H; Reddy S; Xiao W; Guo Y; Gillison ML; D'Souza G
Am J Epidemiol; 2015 Jan; 181(1):40-53. PubMed ID: 25480823
[TBL] [Abstract][Full Text] [Related]
16. Association between self-reported periodontitis and high-risk oral human papillomavirus infection among Indigenous South Australians: A cross-sectional study.
Ali A; Rumbold AR; Kapellas K; Lassi ZS; Hedges J; Jamieson L
PLoS One; 2022; 17(3):e0265840. PubMed ID: 35324953
[TBL] [Abstract][Full Text] [Related]
17. Oral HPV infection in a clinic-based sample of Hispanic men.
Colon-López V; Quiñones-Avila V; Del Toro-Mejías LM; Reyes K; Rivera ME; Nieves K; Sánchez-Vazquez MM; Martínez-Ferrer M; Ortiz AP
BMC Oral Health; 2014 Jan; 14():7. PubMed ID: 24460642
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Epidemiologic Profile of Oral Infection with Alpha, Beta, and Gamma Papillomaviruses in an Asian Chinese Population.
Wong MCS; Vlantis AC; Liang M; Wong PY; Ho WCS; Boon SS; Sze RKH; Leung C; Chan PKS; Chen Z
J Infect Dis; 2018 Jul; 218(3):388-397. PubMed ID: 29982800
[TBL] [Abstract][Full Text] [Related]
19. The association of medication use with clearance or persistence of oral HPV infection.
Lam JO; Sugar EA; Cranston RD; Weber KM; Burk RD; Wiley DJ; Reddy S; Margolick JB; Strickler HD; Wentz A; Jacobson L; Coles CL; Bream JH; Rositch AF; Guo Y; Xiao W; Gillison ML; D'Souza G
Cancer Causes Control; 2016 Dec; 27(12):1491-1498. PubMed ID: 27804058
[TBL] [Abstract][Full Text] [Related]
20. Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer.
D'Souza G; McNeel TS; Fakhry C
Ann Oncol; 2017 Dec; 28(12):3065-3069. PubMed ID: 29059337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
